Download the 2026 Obesity & Weight Loss Drug Development Summit Event Guide

The 4th Obesity & Weight Loss Drug Development Summit is your essential industry platform focused on bridging the gap from novel mechanisms to human impact, driving preclinical and clinical advantage in an increasingly competitive obesity drug development landscape.

Newly added: Breakdown of Companies Attending
4th Obesity & Weight Loss Drug Development 2026 Brochure

Having trouble downloading the brochure? Let us know and we’ll email it to you instead.

Attending Companies Include

antag logo
Canary Global
cirius
Corxel Pharma
eleven therapeutics

Speakers Include

Dan Oieru

Medical Director, Lead Cardiovascular Renal Metabolics, Product Development
Roche

Kenneth Attie

VP
Eli Lilly & Co.

Adi Gilboa-Geffen

Chief Technology Officer
Eleven Therapeutics

Hong Chen

Director - Evaluation & Search
Novo Nordisk